HROW 8-K 2026-10-05
HARROW, INC. (HROW) 8-K dated 2026-10-05 — accession 0001628280-26-064749.
HARROW, INC. (HROW) is a drug manufacturers - specialty & generic company listed on US.
HARROW, INC. filed a 8-K on 2026-10-05. Accession 0001628280-26-064749.
This 8-K covers: Material agreement (Item 1.01), Acquisition or disposition (Item 2.01), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported HROW revenue for 2025-12-31 was $272.3M. Net income was -$5.1M. Revenue was up 36.4% from 2024-12-31 to 2025-12-31. HROW currently screens at market cap $1.28B.
Not investment advice. The HROW SEC hub lists recent forms. The stock page is the research view.